Inflammasome Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
15
NCT06437223
Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 12, 2024
Completion: Jun 30, 2025
Loading map...